EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

In‐Depth Analysis of the Selection of PBPK Modeling Tools: Bibliometric and Social Network Analysis of the Open Systems Pharmacology Community

André Dallmann iD, Donato Teutonico, Stephan Schaller iD, Rolf Burghaus, Sebastian Frechen

The Journal of Clinical Pharmacology · 2024

DOI: 10.1002/jcph.2453 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Clinical Pharmacology, 2024. Verfasst von André Dallmann und 4 weiteren Autor:innen. Beteiligte Einrichtung: Bayer HealthCare SAS, Loos, France. Hauptthemen laut MEDLINE: Bibliometrics, Social Network Analysis, Models, Biological. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Since the Open Source Initiative laid the foundation for the open source software environment in 1998, the popularity of free and open source software has been steadily increasing. Model‐informed drug discovery and development (MID3), a key component of pharmaceutical research and development, heavily makes use of computational models which can be developed using various software including the Open Systems Pharmacology (OSP) software (PK‐Sim/MoBi), a free and open source software tool for physiologically based pharmacokinetic (PBPK) modeling. In this study, we aimed to investigate the impact, application areas, and reach of the OSP software as well as the relationships and collaboration patterns between organizations having published OSP‐related articles between 2017 and 2023. Therefore, we conducted a bibliometric analysis of OSP‐related publications and a social network analysis of the organizations with which authors of OSP‐related publications were affiliated. On several levels, we found evidence for a significant growth in the size of the OSP community as well as its visibility in the MID3 community since OSP's establishment in 2017. Specifically, the annual publication rate of PubMed‐indexed PBPK‐related articles using the OSP software outpaced that of PBPK‐related articles using any software. Our bibliometric analysis and network analysis demonstrated that the expansion of the OSP community was predominantly driven by new authors and organizations without prior connections to the community involving the generation of research clusters de novo and an overall diversification of the network. These findings suggest an ongoing evolution of the OSP community toward a more segmented, diverse, and inclusive network.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BibliometricsSocial Network AnalysisModels, BiologicalHumansSoftwarePharmacokineticsDrug Discovery

Stichwörter der Autor:innen

open sourcephysiologically based pharmacokinetic modeling

Autor:innen und Institutionen

  • Bayer HealthCare SAS, Loos, France.
  • Pharmacometrics/Modeling & Simulation, Research & Development, Pharmaceuticals, Bayer AG, Leverkusen, Germany.
  • Translational Medicine & Early Development, Sanofi-Aventis R&D, Vitry-sur-Seine, France.
  • esqLABS GmbH, Saterland, Germany.

ORCID-Profile: André Dallmann, Stephan Schaller

Zitieren

APA

Dallmann, A., Teutonico, D., Schaller, S., Burghaus, R., & Frechen, S. (2024). In‐Depth Analysis of the Selection of PBPK Modeling Tools: Bibliometric and Social Network Analysis of the Open Systems Pharmacology Community. The Journal of Clinical Pharmacology. https://doi.org/10.1002/jcph.2453

Vancouver

Dallmann A, Teutonico D, Schaller S, Burghaus R, Frechen S. In‐Depth Analysis of the Selection of PBPK Modeling Tools: Bibliometric and Social Network Analysis of the Open Systems Pharmacology Community. The Journal of Clinical Pharmacology. 2024. doi:10.1002/jcph.2453

BibTeX
@article{Dallmann2024,
  author = {Dallmann, André and Teutonico, Donato and Schaller, Stephan and Burghaus, Rolf and Frechen, Sebastian},
  title = {In‐Depth Analysis of the Selection of PBPK Modeling Tools: Bibliometric and Social Network Analysis of the Open Systems Pharmacology Community},
  journal = {The Journal of Clinical Pharmacology},
  year = {2024},
  doi = {10.1002/jcph.2453}
}
Kostenlos starten →